Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer

NCT03327662 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Underrecruitment

Conditions

Adenocarcinoma of the Prostate

Interventions

OTHER: Active CTC Assessment

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]